Abstract
Herein we present a patient that underwent a liver transplant due to primary biliary cholangitis (PBC) and after 9 years developed multiple myeloma. Following the cessation of mycophenolate mofetil and 2 weeks after lenalidomide treatment was started, the patient experienced acute cellular rejection. The patient recovered after treatment with corticosteroids, resumption of mycophenolate mofetil, and cessation of lenalidomide. Lenalidomide-associated allograft rejection has been reported in other organs. However, this is the first case report of liver rejection induced by lenalidomide.
Cite
CITATION STYLE
Vaxman, I., Eaton, J., Lee, H. E., & Gertz, M. A. (2020). Acute Liver Rejection in a Multiple Myeloma Patient Treated with Lenalidomide. Case Reports in Transplantation, 2020, 1–4. https://doi.org/10.1155/2020/8894922
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.